Ofloxacin Use in Acute Kidney Injury

Pharmacokinetic Considerations and Recommendations

Regular monitoring of renal function is required while on ofloxacin therapy in patients with AKI, as recommended by the National Kidney Foundation 1
Before initiating ofloxacin in patients with AKI, consider the severity and cause of the AKI, whether a less nephrotoxic alternative antibiotic is available, the urgency of antimicrobial treatment, and the risk-benefit ratio of using ofloxacin versus delaying treatment, as suggested by the American Society of Nephrology 2
Each additional nephrotoxin administration presents a 53% greater odds of developing AKI, and multiple nephrotoxic medications can more than double the risk of developing AKI, according to the National Institute of Diabetes and Digestive and Kidney Diseases 2

Avoid combining ofloxacin with other nephrotoxic drugs when possible, and minimize the duration and dose of ofloxacin exposure as much as clinically appropriate, as recommended by the European Renal Association 1
Be vigilant for signs of worsening renal function during treatment, and discontinue ofloxacin when evaluation indicates it may be contributing to worsening AKI, as advised by the International Society of Nephrology 1
The decision to use ofloxacin should be based on the severity of infection, available alternatives, and the patient's current renal function with appropriate dose adjustments, considering the guidelines from the Infectious Diseases Society of America 2